Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Mar;25(3):755.
doi: 10.1093/annonc/mdt596. Epub 2014 Jan 23.

Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer

A Goldhirsch  1 , A S Coates  2
Affiliations
Comment

Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer

A Goldhirsch et al. Ann Oncol. 2014 Mar.

Abstract

The St.Gallen Consensus was accurate in providing a balanced opinion on the prognostic and predictive value of several tests, including gene profiling.

PubMed Disclaimer

Comment on

References

    1. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206–2223. - PMC - PubMed
    1. Schmidt M, Untch M. Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer: a problem still to be solved (letter) Ann Oncol. 2013 - PMC - PubMed
    1. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726–3734. - PubMed
    1. Albain KS, Barlow WE, Shak S, et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 2010;11:55–65. - PMC - PubMed